
Superluminal Medicines secures $60M for obesity drug trial by 2026 end
Superluminal Medicines raises $60M Series B to advance AI-driven obesity drug into clinical trials by year-end 2026.
News, trends, and insights from the AI frontier.
Latest Series B coverage.

Superluminal Medicines raises $60M Series B to advance AI-driven obesity drug into clinical trials by year-end 2026.

Carrick Capital closes $600M continuation vehicle, commits $255M to Saviynt's AI identity security platform Zuma.

Isomorphic Labs leads AI biotech funding with a $2.1B round as the sector attracts $6B in 2026, per Crunchbase data.

IndiGo Ventures backs Sarvam AI in its Series B round to enhance aviation AI capabilities and operational efficiency

Instinct raises $250M for AI assistants, topping a week of smaller but notable AI startup funding rounds.

Stability AI raises $76M from Sony, EA, and top music labels to build AI tools for entertainment professionals

Instinct, a 23-year-old founder's AI assistant startup, raises $350M at a $2.5B valuation, co-led by Index Ventures and Benchmark.

Singapore-based 1982 Ventures invests in US AI startup Higgsfield's $400M Series B round, valuing it at $5.4B.

Generalist, a robotics startup, raises $200M at a $3B valuation to advance its AI foundation model for robots.

Korea's tech funding surged 195% to $1.4B in H1 2026, driven by AI chipmaker Rebellion's $400M Series D and XCENA's $135M Series B.

Wispr raises $280M in Series B, nearly tripling its valuation to $2B as it expands beyond dictation into workplace productivity.

Anthropic is close to acquiring Israeli AI startup Decart for $7B, despite a higher offer from Nvidia, as it prepares for a potential IPO.

Point2 Technology raises $80M Series B extension, bringing total funding to $140M for AI interconnect solutions.

Blacksmith secures $45M Series B funding led by Peak XV, valuing the AI code testing startup at $550M.

Aureka secures $100M Series B to advance its AuraIDE biological foundation model and compete with AlphaFold in AI4S.

Two LA startups secure $2.37B to build factories and nuclear reactors for AI's power and hardware needs.

Nvidia invests $75M in Sarvam AI, its first Indian startup bet, as part of a $300M funding round.

Valar Atomics secures $1B Series B funding to power AI infrastructure with nuclear energy, aiming for rapid reactor scaling.

Onyx Security raises $113M Series B, hitting $640M valuation as it secures AI agents for enterprises.

Generalist AI raises $400M Series B to develop AI-powered robotics for real-world tasks, backed by NVIDIA and Union Square Ventures.

Insurance tech startup Corgi raises another round, doubling its valuation to $4B in just eight weeks, driven by rapid revenue growth.

Fireworks AI, an AI platform for open-source models, raises $1.5B, bringing its total equity funding to $1.8B.

CuspAI, backed by Jeff Bezos and the UK government, raises $450m to develop AI-driven materials discovery software.

Jeff Bezos' Prometheus raises $12 billion to advance AI-driven physical product design and manufacturing, hitting a $41 billion valuation.

Parallel Web Systems, led by ex-Twitter CEO Parag Agrawal, raises $2B at a $10B valuation to advance AI infrastructure.

Auger raises $50M Series B to expand its AI-driven supply chain platform, now handling 85% of Fanatics' decisions.

MiniMax AI seeks $2.05B in funding to accelerate AI development and global expansion, despite investor concerns over dilution.